True Wealth Design’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-983
Closed -$99.8K 2749
2025
Q4
$99.8K Buy
983
+375
+62% +$30.1K 0.03% 188
2025
Q3
$33.3K Buy
608
+19
+3% +$949 0.01% 436
2025
Q2
$31.3K Buy
589
+533
+952% +$27.1K 0.01% 287
2025
Q1
$2.42K Buy
56
+3
+6% +$152 ﹤0.01% 941
2024
Q4
$2.98K Sell
53
-216
-80% -$13.4K ﹤0.01% 646
2024
Q3
$18.3K Sell
269
-37
-12% -$2.09K 0.01% 333
2024
Q2
$12.9K Buy
306
+300
+5,000% +$16.5K ﹤0.01% 233
2024
Q1
$415 Buy
6
+3
+100% +$190 ﹤0.01% 664
2023
Q4
$222 Hold
3
﹤0.01% 660
2023
Q3
$205 Hold
3
﹤0.01% 632
2023
Q2
$282 Sell
3
-600
-100% -$46.8K ﹤0.01% 597
2023
Q1
$40.9K Buy
603
+1
+0.2% +$64 0.02% 170
2022
Q4
$29.8K Buy
+602
New +$24.6K 0.01% 173

Other funds holding EXAS

True Wealth Design's EXAS Position: Q1 2026 in Review

True Wealth Design sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 983 shares — an estimated $99.8K sold.

True Wealth Design first reported a position in EXAS in Q4 2022 and held it in 13 quarters. The position peaked at $99.8K in Q4 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • True Wealth Design reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • True Wealth Design sold 983 Exact Sciences shares in Q1 2026, an estimated $99.8K.
  • True Wealth Design first reported a position in Exact Sciences in Q4 2022 and held it in 13 quarters.
  • True Wealth Design's Exact Sciences position peaked at $99.8K in Q4 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on True Wealth Design's 13F filing for Q1 2026, filed 13 Apr 2026.